Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;102(2):115561.
doi: 10.1016/j.diagmicrobio.2021.115561. Epub 2021 Oct 11.

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme

Affiliations

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme

Alena Moerman et al. Diagn Microbiol Infect Dis. 2022 Feb.

Abstract

We report on sample IS/17575 since it generated highly divergent results in the Belgian SARS-CoV-2 serology external quality assessment scheme. Sample IS/17575 was serum originating from a 30 years old male patient. 124 diagnostic laboratories analysed this sample. A total of 168 results was returned (including 5 doubles). Overall, 38 were positive. All tests against S1 were positive except the Euroimmun IgG ELISA and the Ortho clinical Diagnostics VITROS IgG CLIA. All tests against S1/S2 (Liaison, Diasorin) resulted in a signal above cutoff. Assays against RBD, mostly generate a negative result. An exception are the Wantai SARS-CoV-2 ELISA's. All tests targeting N protein were negative. The survey shows, when >6 months post-infection, assays targeting at least S1, and preferably S1 combined with S2, are the most sensitive. This finding accentuates the necessity of external quality assessment schedules and importance of antigenic composition of serologic SARS-CoV-2 assays.

Keywords: Nucleocapsid protein; SARS-CoV-2; Spike protein; external quality assessment scheme; receptor-binding domain; serology.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The author stated that there are no conflicts of interest regarding the publication of this article.

Figures

Fig 1
Fig. 1
Graphic representation of the number of positive, borderline and negative results, recovered from the EQA (sample IS/17575), stratified per antigen.

References

    1. Acro biosystems. How does the COVID-19 antibody ELISA test function? 2021; Available at: https://www.acrobiosystems.com/A1125-How-does-the-COVID-19-antibody-ELIS.... Accessed February 22, 2021.
    1. Bryan A, Pepper G, Wener MH, Fink SL, Morishima C, Chaudhary A, et al. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. 2020;58(8):e00941–20. - PMC - PubMed
    1. Cai Y, Zhang J, Xiao T, Peng h, Sterling SM, Walsh RM, Jr., et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586–1592. - PMC - PubMed
    1. Egger M, Bundschuh C, Wiesinger K, Gabriel C, Clodi M, Mueller T, et al. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma. Clin Chim Acta. 2020;509:18–21. - PMC - PubMed
    1. Fenwick C, Croxatto A, Coste AT, Pojer F, André C, Pellaton C, et al. Changes in SARS-CoV-2 spike versus nucleoprotein antibody response impact the estimates of infections population-based seroprevalence studies. J Virol. 2021;95(3):e01828–20. - PMC - PubMed